-
-
-
-
-
-
-
RedHill explores opaganib for ebola outbreak response
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports 14% Revenue Growth
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/30: (CPIX) (IMGN) (VIR) Higher; (JKS) (LIZI) (SEDG) Lower (more...)
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019
-
1,165,640 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

